Clinical Trial Update: Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial [Phase 4]

View source ↗

Summary

Phase 4 randomized controlled trial evaluating whether telbivudine provides renoprotective effects in patients with hepatitis B-related liver cirrhosis; current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hbv-related Liver Cirrhosis

Drugs mentioned

• Telbivudine (telbivudine)

Snippet

Sponsor: Lin Bingliang | Conditions: HBV-related Liver Cirrhosis | Phase 4 | Status: UNKNOWN